Moderna Stock Drops After Lowering Sales Forecast

Reported 3 months ago

Moderna's shares have plummeted after the company revised its sales forecast downward due to decreased demand for COVID and RSV vaccines. This shift comes against a backdrop of uncertainty surrounding the incoming Trump administration and its potential impact on pharmaceutical regulations, particularly with the nomination of Robert F. Kennedy Jr., known for his vocal anti-vaccine stance.

You may also interested in these wikis

Concerns Rise Over Corporate Earnings as Dollar Weakens

Worldline Delays Earnings Guidance Amid Strategic Changes

Boeing's Critical Push for Increased 737 Max Production

European Car Sales Increase in March, Tesla Faces 28.2% Decline

Mortgage Rates Decrease Slightly Despite Market Volatility

Kering Shares Fall 5% Due to Disappointing Q1 Sales

Here’s an Easy Way to Earn Income for Doing Almost Nothing

Taiwan Semiconductor's Arizona Factory Hit Hard by $441 Million Loss Due to Supply Chain Issues

How are the Trump tariffs affecting you? Take our survey and let us know.

Back to all Wikis